The new feature analyzes 50+ biomarkers and uses AI to translate lab results into personalized health insights, intensifying competition in the fast-growing longevity diagnostics market
Amazon just became the next major player to enter the biomarker blood-testing wars with the launch of Health Insights.
The new beta feature, developed in partnership with the Tony Robbins co-founded telehealth and longevity company Lifeforce, provides analysis of over 50 biomarkers from lab blood-test results.
The Health Insights tool translates blood test results into actionable insights segmented into three categories: cardiovascular, metabolic and immune health.
“Health Insights brings clarity to complex health data and gives providers another way to help our members understand what their lab results mean — so together, they can focus on what matters most: personalized care and better health outcomes,” said Amazon One chief medical officer Dr. Andrew Diamond.
Using One Medical’s artificial intelligence-powered agent, Health AI, members can have real-time conversations about what the Health Insights analysis means for them specifically, with the ability to ask follow-up questions about biomarker results, clarify medical terminology, understand how different health metrics are connected and understand trends over time.
The service is included at no additional cost to those already with a One Medical membership.
Eligible members can access Health Insights in the One Medical app. After completing a brief questionnaire, the feature then generates:
- A wellness score based on their unique biomarker profile
- Detailed analysis of individual biomarkers categorized by health domain (cardiovascular, metabolic or immune health)
- Science-backed lifestyle recommendations around nutrition, physical activity, stress management and sleep, with scientific references supporting each recommendation
The new feature arrives as the biomarker blood-testing market continues to explode amid the rise of longevity science and rising distrust of traditional healthcare.
One of the biggest diagnostic testing brands out there, Function Health, raised $298 million in a Series B round that valued the company at a staggering $2.5 billion last November.
Meanwhile, telehealth giant Hims & Hers made its entrance into diagnostic testing, introducing a subscription-based service that offers annual or biannual blood tests and doctor-informed recommendations for lifestyle changes or treatment options.
